Across TCGA pan-cancer cohorts, ANHX Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ANHX data layer compared with 15 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ANHX Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ANHX expression acts as an unfavorable survival marker.

UCEC and SCLC are the cancer types where ANHX Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SCLC	OS	Median	All	0.219	0.650	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ANHX tumor-vs-normal RNA expression · all ANHX data types